Cardiovascular Risks of GLP-1 Medications GLP-1 receptor agonists, like semaglutide, liraglutide, dulaglutide, and tirzepatide, are widely used for managing type 2 diabetes and obesity
Recognising this, we are proud to announce that we are bringing Wegovy to Indians as a transformative and evidence-based therapeutic solution with the convenience of a world-class, state-of-the-art pen device," said Vikrant Shrotriya, Managing Director, Novo Nordisk India, announcing Wegovy's launch in India on Tuesday
Additionally, retatrutide is still in the trial phase, is not available to the general public yet, and we do not have enough safety data on this newer drug
Not for parental use
Treatment choice depends on severity, frequency of recurrence, pregnancy status, and whether the infecting species is typical Candida albicans or a different strain
Statistical analysis Changes in the number of PBS/RPBS semaglutide and dulaglutide prescriptions supplied in each calendar month with time between January 2021 and September 2022 were analysed